Concentra Group Holdings Parent (CON) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $39.15, +4.51% vs the prior close of $37.46.
- Volume 1.66M shares, 1.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CON jumps 4.5% to $39.15, a 52-week high. Closed at $39.15, +4.51% vs the prior close of $37.46. Day range $37.56–$39.24, opened at $37.74.
CON daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CON jumps 4.5% to $39.15, a 52-week high
- Closed at $39.15, +4.51% vs the prior close of $37.46. Day range $37.56–$39.24, opened at $37.74.
- Volume was 1.66M shares, 1.6x its 50-day average of 1.01M.
- Price is +11.4% vs its 50-day average ($35.13) and +42.8% vs its 200-day average ($27.41).
- 52-week range $18.55–$39.24; today's close sits at 100% of that range, 0.2% below the 52-week high.
Oct 14, 2026 — CON ends flat (-0.2%) to $37.46 on 2.6x normal volume
- Closed at $37.46, -0.21% vs the prior close of $37.54. Day range $37.29–$38.16, opened at $37.85.
- Volume was 2.53M shares, 2.6x its 50-day average of 974.78K — unusually heavy trading.
- Price is +7.1% vs its 50-day average ($34.97) and +37.1% vs its 200-day average ($27.32).
- 52-week range $18.55–$38.16; today's close sits at 96% of that range, 1.8% below the 52-week high.
Oct 13, 2026 — CON ends flat (+0.0%) to $37.54
- Closed at $37.54, +0.00% vs the prior close of $37.54. Day range $37.33–$38.07, opened at $37.79.
- Volume was 885.40K shares, 0.9x its 50-day average of 969.20K.
- Price is +7.8% vs its 50-day average ($34.84) and +37.9% vs its 200-day average ($27.23).
- 52-week range $18.55–$38.07; today's close sits at 97% of that range, 1.4% below the 52-week high.
Oct 12, 2026 — CON rises 0.9% to $37.54, a 52-week high, 3 up days in a row
- Closed at $37.54, +0.94% vs the prior close of $37.19. Day range $37.08–$37.76, opened at $37.28.
- Volume was 1.00M shares, 1.0x its 50-day average of 960.27K.
- Price is +8.1% vs its 50-day average ($34.72) and +38.3% vs its 200-day average ($27.14).
- 52-week range $18.55–$37.76; today's close sits at 99% of that range, 0.6% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — CON rises 1.6% to $37.19, a 52-week high
- Closed at $37.19, +1.58% vs the prior close of $36.61. Day range $36.24–$37.29, opened at $36.75.
- Volume was 1.06M shares, 1.1x its 50-day average of 953.81K.
- Price is +7.5% vs its 50-day average ($34.60) and +37.5% vs its 200-day average ($27.05).
- 52-week range $18.55–$37.29; today's close sits at 99% of that range, 0.3% below the 52-week high.
Oct 8, 2026 — CON rises 0.6% to $36.61, a 52-week high
- Closed at $36.61, +0.58% vs the prior close of $36.40. Day range $36.02–$36.94, opened at $36.27.
- Volume was 1.19M shares, 1.3x its 50-day average of 945.56K.
- Price is +6.1% vs its 50-day average ($34.49) and +35.8% vs its 200-day average ($26.96).
- 52-week range $18.55–$36.94; today's close sits at 98% of that range, 0.9% below the 52-week high.
Oct 7, 2026 — CON ends flat (+0.0%) to $36.40
- Closed at $36.40, +0.00% vs the prior close of $36.40. Day range $36.30–$36.72, opened at $36.41.
- Volume was 1.29M shares, 1.4x its 50-day average of 932.62K.
- Price is +5.8% vs its 50-day average ($34.39) and +35.4% vs its 200-day average ($26.88).
- 52-week range $18.55–$36.83; today's close sits at 98% of that range, 1.2% below the 52-week high.
Oct 6, 2026 — CON rises 0.5% to $36.40, a 52-week high, 4 up days in a row
- Closed at $36.40, +0.52% vs the prior close of $36.21. Day range $36.15–$36.83, opened at $36.53.
- Volume was 906.40K shares, 1.0x its 50-day average of 924.88K.
- Price is +6.1% vs its 50-day average ($34.32) and +35.8% vs its 200-day average ($26.79).
- 52-week range $18.55–$36.83; today's close sits at 98% of that range, 1.2% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — CON rises 1.6% to $36.21, 3 up days in a row
- Closed at $36.21, +1.57% vs the prior close of $35.65. Day range $35.48–$36.51, opened at $35.99.
- Volume was 1.04M shares, 1.1x its 50-day average of 929.23K.
- Price is +5.8% vs its 50-day average ($34.23) and +35.6% vs its 200-day average ($26.71).
- 52-week range $18.55–$36.71; today's close sits at 97% of that range, 1.4% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — CON rises 1.9% to $35.65
- Closed at $35.65, +1.94% vs the prior close of $34.97. Day range $34.90–$36.18, opened at $35.32.
- Volume was 1.38M shares, 1.5x its 50-day average of 915.41K.
- Price is +4.4% vs its 50-day average ($34.14) and +33.9% vs its 200-day average ($26.63).
- 52-week range $18.55–$36.71; today's close sits at 94% of that range, 2.9% below the 52-week high.
CON latest news & SEC filings
Every SEC filing by or about CON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 8, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 1, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · 4/A — Amended insider trade report (Form 4/A)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 25, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 24, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $606.03M (prior year $550.78M) (+10.0% vs Jun 30, 2025)
- Net income: $65.30M (prior year $44.56M) (+46.5% vs Jun 30, 2025)
- Diluted EPS: $0.51 (prior year $0.35) (+45.7% vs Jun 30, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ortenzio Robert A sold 130,000 shares at $31.84 (≈$4.14M) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 3, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 27, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ortenzio Robert A sold 130,000 shares at $30.50 (≈$3.96M) on Jul 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 1, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Things to know before you trade CON
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 28, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.07% (largest 4.5%).
- Liquidity: about 1.23M shares (≈$48.15M) trade per day on average.
- 52-week position: $39.15 vs a range of $18.55–$39.24 (100% of the range).
- Dividends: last ex-dividend date Aug 20, 2026 ($0.063/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 4 sales; latest: Robert A Ortenzio sold 130,000 shares on Aug 3, 2026.
- Latest filings: 8-K Sep 8, 2026; 8-K Aug 27, 2026; 10-Q Aug 6, 2026.
- Share count: 127.52M shares outstanding (Jul 31, 2026), -0.5% vs a year earlier.
- Listing: NYSE · industry: Services-Specialty Outpatient Facilities, NEC.
CON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 37.74 | 39.24 | 37.56 | 39.15 | 1.66M |
| Oct 14, 2026 | 37.85 | 38.16 | 37.29 | 37.46 | 2.53M |
| Oct 13, 2026 | 37.79 | 38.07 | 37.33 | 37.54 | 885.40K |
| Oct 12, 2026 | 37.28 | 37.76 | 37.08 | 37.54 | 1.00M |
| Oct 9, 2026 | 36.75 | 37.29 | 36.24 | 37.19 | 1.06M |
| Oct 8, 2026 | 36.27 | 36.94 | 36.02 | 36.61 | 1.19M |
| Oct 7, 2026 | 36.41 | 36.72 | 36.30 | 36.40 | 1.29M |
| Oct 6, 2026 | 36.53 | 36.83 | 36.15 | 36.40 | 906.40K |
| Oct 5, 2026 | 35.99 | 36.51 | 35.48 | 36.21 | 1.04M |
| Oct 2, 2026 | 35.32 | 36.18 | 34.90 | 35.65 | 1.38M |
| Oct 1, 2026 | 34.26 | 35.25 | 34.05 | 34.97 | 876.40K |
| Sep 30, 2026 | 35.39 | 35.42 | 34.39 | 34.42 | 1.09M |
| Sep 29, 2026 | 36.06 | 36.06 | 34.83 | 35.34 | 587.40K |
| Sep 28, 2026 | 34.77 | 35.56 | 34.75 | 35.36 | 587.80K |
| Sep 25, 2026 | 34.32 | 35.07 | 34.32 | 35.01 | 571.40K |
| Sep 24, 2026 | 34.61 | 35.20 | 34.41 | 34.62 | 841.40K |
| Sep 23, 2026 | 34.85 | 35.22 | 34.54 | 34.79 | 815.40K |
| Sep 22, 2026 | 34.48 | 35.44 | 34.48 | 34.88 | 681.30K |
| Sep 21, 2026 | 35.31 | 35.51 | 34.59 | 34.77 | 743.20K |
| Sep 18, 2026 | 35.56 | 35.66 | 34.78 | 35.47 | 4.87M |
About Concentra Group Holdings Parent
Concentra Group Holdings Parent (CON) is listed on the NYSE and classified by the SEC under “Services-Specialty Outpatient Facilities, NEC”. Its business address is in ADDISON, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2014596.
CON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Brigid A. Bonner | Director | Nov 6, 2025 |
| Vipin Gopal | Director | Nov 6, 2025 |
| William Keith Newton | Chief Executive Officer | Dec 18, 2025 |
| Robert A Ortenzio | Director | Sep 1, 2026 |
| Cheryl Pegus | Director | Nov 6, 2025 |
| Daniel Thomas | Director | Nov 6, 2025 |
| Marc R. Watkins | Director | Nov 6, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Robert Jr. Anderson | See Remarks | Dec 1, 2025 |
| Jonathan P. Conser | See Remarks | Dec 1, 2025 |
| Thomas A. Devasia | See Remarks | Dec 1, 2025 |
| Matthew T. Dicanio | See Remarks | Dec 1, 2025 |
| Giovanni Gallara | See Remarks | Dec 1, 2025 |
| Greg M. Gilbert | See Remarks | Dec 1, 2025 |
| Danielle Kendall | See Remarks | Dec 1, 2025 |
| Michael A. Kosuth | See Remarks | Dec 1, 2025 |
| Douglas R. Mcandrew | See Remarks | Dec 1, 2025 |
| Su Zan Nelson | See Remarks | Dec 1, 2025 |
| William Keith Newton | Chief Executive Officer | Dec 18, 2025 |
| Michael D. Rhine | See Remarks | Dec 1, 2025 |
| Timothy F. Ryan | See Remarks | Dec 1, 2025 |
| John A. Delorimier | See Remarks | Dec 1, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 3, 2026 | Robert A Ortenzio | Sale | 130,000 | $31.84 |
| Jul 1, 2026 | Robert A Ortenzio | Sale | 130,000 | $30.50 |
| Jun 1, 2026 | Robert A Ortenzio | Sale | 130,000 | $25.00 |
| May 8, 2026 | Robert A Ortenzio | Sale | 130,000 | $25.00 |
CON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.16B | $166.41M | 1.30 | $279.40M |
| Dec 31, 2024 | $1.90B | $166.54M | 1.46 | $274.68M |
| Dec 31, 2023 | $1.84B | $179.95M | 1.73 | $234.32M |
| Dec 31, 2022 | $1.72B | $166.73M | 1.60 | $274.34M |
Latest balance sheet: total assets $3.01B, total liabilities $2.50B, cash $158.04M (as of Jun 30, 2026).
CON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $30.54 |
| May 7, 2026 | 8-K Item 2.02 (results) | $23.60 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $23.64 |
| Jan 28, 2026 | 8-K Item 2.02 (results) | $21.48 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $20.61 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $18.71 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $20.20 |
| May 7, 2025 | 8-K Item 2.02 (results) | $21.87 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $22.38 |
| Jan 23, 2025 | 8-K Item 2.02 (results) | $23.60 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $20.27 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Specialty Outpatient Facilities, NEC
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.